The growth of Eimeria vermiformis within cultured murine fibroblastlike (L-929) or rat epitheliallike (RATEC) cells was inhibited by treatment of the cells with the appropriate recombinant gamma interferon. The effect was apparent as a reduction in both the initial numbers of intracellular sporozoites and, to a much greater extent, the numbers of subsequent developmental stages. Pretreatment of the host cells was more effective than treatment in the early postinvasive period, and recombinant gamma interferon had no effect on the development of the parasite if added 24 h or later after the inoculation of sporozoites. Incubation of sporozoites in medium containing recombinant gamma interferon in no way affected their ability to invade or to grow within host cells. These findings indicate that the inhibitory effects of recombinant gamma interferon on the growth of E. vermiformis are mediated via the host cell and are directed mainly against the transforming sporozoite, although the ability of the sporozoite to invade the host cell was also reduced to some extent. The later developmental stages were refractory to the effects of this lymphokine.
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Gamma interferon (IFN--y) has been shown to play an important part in the defense of the host against several intracellular protozoan diseases; for example, malaria (8, 14, 31, 32) , leishmaniasis (18, 19, 28) , Chagas' disease (23) , and toxoplasmosis (15, 17, 35) . It is also implicated in the control of coccidiosis, an economically important disease of domestic animals, especially poultry, caused by protozoa of the genus Eimeria, which parasitize enterocytes. In a murine model system, depletion of endogenous IFN--y by treatment with specific neutralizing monoclonal antibodies led to seVere, often fatal, infections with Eimeria vermiformis in a strain of mouse that is normally resistant to this species (27) and greatly increased the severity of the clinical signs produced by infection with Eimeria pragensis in BALB/c, NIH, and C57BL/6 mice (27a). As a component of the cytokine network, IFN-y has a major immunomodulating activity, regulating the cells of the immune system and the expression of cell surface antigens, including those of the major histocompatibility complex; it also has cytostatic and antimicrobial effects (4, 36) . Either or both of these major types of function may operate against intracellular protozoa, and a knowledge of their relative importance, in the case of any particular organism, is necessary for devising rationally based means for control by vaccination. In the case of leishmania (19) and Trypanosoma cruzi (23) , exogenous IFN-y has been shown to activate macrophages for antimicrobial activity, whereas it can act more directly against plasmodia by inhibiting the extraerythrocytic developmental stages within hepatocytes (8, 16, 31) . In the case of toxoplasma, IFN-y is thought to be effective both by activation of macrophages (35) and by inhibition of growth within cells that are not immune effectors (22) . Inhibition of the development of Eimeria spp. within cultured monocytes or macrophages by crude supernatants of both specific antigen-and concanavalin A-stimulated lymphocytes has been described (9, 20, 34) , but in vivo the activation of professional phago-* Corresponding author. cytes may not be of major importance since the host cell is normally an enterocyte.
More recently, Kogut and Lange (11, 12) found that pretreatment of cultured kidney or epidermoid carcinoma cells with crude supernatants from concanavalin A-stimulated T lymphocytes or with appropriate recombinant IFN-y (rIFN--y) led to reduced invasion by eimerian sporozoites and inhibition of their development. Additionally, but surprisingly, Lillehoj et al. (13) reported decreased growth of Eimeria tenella in a bovine kidney cell line (MDBK) that had been pretreated with crude supernatants from nonspecifically or specifically stimulated chicken T cells or from a cultured Marek's disease virus-transformed, chicken-derived, T-cell line. Since macrophages were not involved in either case, the antiparasite effect of IFN-,y clearly was mediated via the host cell.
In this report we describe the effects of murine (mrIFN--y) or rat (rrIFN--y) rIFN--y on the development of E. vermiformis in cultured murine fibroblasts (L-929 cells) or rat epithelial cells (RATEC cells) and show that (i) both invasion and growth of the parasite are inhibited, and (ii) the antidevelopmental effects of the lymphokine are directed against the newly invaded sporozoite and later developmental stages are unaffected.
MATERIALS AND METHODS
Parasites. The origin and methods of propagation of E. vermiformis have been described elsewhere (26) . Sporozoites were excysted from mechanically broken (21) oocysts by incubation in trypsin-bile solution, as recommended for E. tenella by Chapman (6) , and purified by passage through DE-52 cellulose (30 Effect of mrIFN--y on growth of E. vermiformis in cultured L-929 cells. In preliminary dose-response experiments, the protocol for treatment with rIFN--y was similar to that used for investigations involving plasmodia (31); i.e., cells were pretreated with rIFN--y for 6 h, dishes were washed, and sporozoites were inoculated (time 0 h) and allowed to invade for 3 h, at which time the inoculation medium was replaced with mrIFN--y-containing (test) medium. Incubation was continued for up to 45 h after inoculation, with removal and replacement of test medium at 24 and 36 h. Control dishes were similarly treated with IFN-free medium. The results obtained with concentrations of mrIFN-y ranging from 1 to 100 U/ml of culture medium and L-929 cells are given in Fig.  2a . mrIFN--y at 1 U/ml had no significant effect on the invasion or growth of the parasites, but mrIFN--y at 10, 50, or 100 U/ml had a profound effect upon growth and a slight but significant (P = 0.03 for 10 U/ml, P = 0.04 for 100 U/ml) effect upon invasion. Interestingly, the development of the small numbers of parasites present at 36 or 45 h on coverslips treated with 10 to 100 U of mrIFN--y per ml was trations of mrIFN--y lagged behind that seen in the control coverslips or in coverslips treated with 1 U of mrIFN-y per ml. However, this comparison is of doubtful validity, since development is incomplete and variable at this time and the numbers of intracellular parasites present in the treated coverslips are low. These results were confirmed in other experiments that included dishes treated with 1,000 U of IFN--y per ml (data not shown). The findings obtained with RATEC cells treated with rrIFN--y were very similar (Fig.  lb) . A standard dose of 100 U of rIFN--y per ml was adopted in subsequent experiments.
Effect of pretreatment of sporozoites of E. vermiformis with mrIFN--y. To determine whether pretreatment of sporozoites could affect their ability to invade L-929 cells, they were incubated at 106/ml in FCS-free medium containing 100 U of mrIFN-y per ml for 30 min at 37°C; after sporozoites were washed to remove mrIFN--y, they were inoculated onto L-929 cells and cultured for up to 45 h. The results obtained with coverslips sampled at 3, 24, 36, and 45 h did not differ from those found with control coverslips from dishes that had been inoculated with sporozoites preincubated in mrIFN--y-free medium (Fig. 3) .
Effect of timing of treatment of host cells with rIFN--y on growth of E. vermniformis: developmental stage affected. The effects of varying the length of pretreatment of L-929 cells and of application of mrIFN--y after the invasion of sporozoites are shown in Fig. 4 . Included as known positive controls were dishes treated as in the dose-response experiment described above (Fig. 2) ; i.e., cells were pretreated from -6 to 0 h, and rIFN--y was renewed at each time of sampling (multiple application).
As in the dose-response experiments, two types of effect were apparent: first, a reduction in the initial number of intracellular parasites, i.e., sporozoites (sampled at 3 h), and, second, a further reduction in the numbers of subsequent developmental stages (sampled at 24, 36, and 45 h). There was no significant effect on the development of the ites (106/ml) were incubated in serum-free medium containing 100 U of mrIFN-y per ml for 30 4 . Effect of differing treatments with mrIFN--y on invasion and growth of E. vermiformis in cultured L-929 cells. Monolayers were treated with mrIFN-y (100 U/ml) for the times indicated. For the multiple application, monolayers were pretreated from -6 to 0 h, and rIFN--y was renewed at each time of sampling, i.e., at 3, 24, and 36 h. Sporozoites in IFN--y free medium were inoculated at 0 h. parasites that persisted. The effect on the initial numbers of intracellular sporozoites (invasion) varied directly with the length of pretreatment between -24 to 0 h and -6 to 0 h (P < 0.013); the difference between -6 to 0 h and -3 to 0 h was not significant. Reduction in the numbers of subsequent intracellular parasites was also directly related to the length of pretreatment and, in the case of 24-h pretreatment, was equivalent to the inhibition found with the standard treatment (i.e., pretreatment for 6 h with renewal from 3 h until time of sampling). Posttreatment from 3 h postinoculation had the effect of halving the number of subsequent stages, but, if delayed until 24 or 36 h postinoculation, it was ineffective; there were no differences between the numbers of intracellular parasites found at 36 and 45 h or at 45 h, respectively. Thus, intracellular parasites after invasion must have been affected within the first 24 h. Similar results were obtained with RATEC cells and rrIFN-y (data not shown).
Since pretreatment of the host cells caused a reduction in the numbers of intracellular sporozoites present at 3 h, it was necessary to determine whether this effect was uniformly exerted throughout the period allowed for invasion (0 to 3 h) or became apparent at a particular time point. The kinetics of invasion did not appear to be altered as a result of IFN--y treatment of the host cells (Fig. 5a ). In Figure 5b gives the results of a similar experiment, which included cultures pretreated from -48 to -24 h, washed to remove mrIFN--y, and incubated in normal medium for 24 h before the inoculation of sporozoites. The numbers of sporozoites that invaded these cells were significantly lower (P = 0.0001) than those in untreated cultures, indicating that the host cells had not recovered from treatment in the course of 24 h of incubation in IFN-free medium.
The effects of treatment of L-929 cells with mrIFN--y on the critical postinvasion period between 3 and 24 h are shown in Fig. 6 . As expected, there were significantly fewer (P s 0.005) parasites in treated monolayers than in control cells at all times of sampling. In the IFN-treated cells there was a marked decline in the numbers of intracellular parasites within the first 9 h after invasion (P = 0.003 and P = 0.001 for differences between 3 and 6 h and between 6 and 9 h, respectively), after which the numbers of parasites fell gradually until 45 h. In the untreated cells, on the other hand, there was no significant change between successive samplings, but, unusually, fewer parasites were present at 45 h than at 3 h (P = 0.001). The results confirm the deleterious effect of IFN early in development and indicate that it is most marked within the first 12 h of incubation. We could zoites in any incubation in mrIFN--y, confirming results obtained for E. tenella and bovine rIFN--y (11, 12) . Similarly, human rIFN--y (hrIFN--y) had no effect on the viability of extracellular tachyzoites of Toxoplasma gondii (22 (16) suggested that inhibition of the development of Plasmodium falciparum was the result of mechanisms *-*- § that were active only after penetration. The quantitative aspects of an effect on invasion by other eimerian developmental stages (i.e., merozoites) could not be examined in our system due to the limitation of growth to the first generation mFN-f, 100 U/ni of schizogony.
The mechanisms of invasion and inhibition are not known, 24 45 but, since sporozoites were not affected directly and the Xzolt|| effect increased with the length of pretreatment, it is likely s with mrIFN-y that the mechanisms involve alterations in the surface mem- vivo (2, 24, 25) . The major effect of treatment with IFN--y, which was both dose (Fig. 2) and exposure time (Fig. 4) dependent, was evident as a greatly decreased number of parasites at 12 h and subsequent times of sampling. This suggests that the transforming sporozoite could be the target of attack, a hypothesis that was supported by the lack of effect of rIFN--y when added to cultures at 24 h or later, i.e., after the sporozoites had begun to transform. It is possible that subsequent invasive forms, i.e., merozoites, could also be affected at this stage, but it was not possible to examine this in our system. Interestingly, the few parasites that survived in cells pretreated or treated at an early stage with rIFN--y appeared normal and had developed to the same extent as those within control, untreated host cells. In contrast, the development of the reduced numbers of E. tenella present in bovine rIFN--y-treated MDBK cells was reported to be inhibited, with "less than 30% of the parasites present developing beyond the sporozoite stage," and the undeveloped sporozoites were "normal looking as judged by light microscopy" (12) . The reason for these discrepancies is not immediately apparent but may reflect differences in the species of parasite and the host cell. That such differences may be relevant is evident from previous work. Thus, Speer et al. (34) reported that sporozoites of Eimeria bovis, whose development in bovine monocytes had been inhibited by pretreatment of the host cells with concanavalin A-stimulated lymphocyte supernatants, appeared structurally normal, whereas sporozoites of Eimeria papillata examined in the same system were destroyed intracellularly. Also, Schwartzman et al. (33) , while confirming the inhibition of growth of T. gondii in human fibroblasts pretreated with hrIFN--y (22) , found that similar treatment of murine fibroblasts (L-929 cells) with mrIFN-y had no such effect. This was attributed to the inability of the L-929 cells to produce indoleamine 2,3-dioxygenase, which degrades tryptophan, in response to treatment. This finding suggests that tryptophan starvation was not the cause of the reduction in numbers of eimeria observed by us in mrIFN--y-treated L-929 cells. Tryptophan starvation has also been discounted as being responsible for the antimalarial activity of hrIFN--y in cultured hepatocytes (31) . We cannot speculate on the means by which treatment with IFN--y affects the transformation of eimerian sporozoites because this process is little understood, although it does seem to involve the metabolism of glucose (37) .
Some of the mechanisms responsible for the antiviral effects induced by IFN treatment are known, but these may differ from those which inhibit cell proliferation by altering intracellular metabolism (3); either or both types could be responsible for intracellular antieimeria activity. It is unlikely that a nonspecific adverse effect of IFN--y on the host cells was responsible for our findings, since the monolayers retained their integrity throughout incubation and the antieimeria effects were apparent only against the initial development of the parasite. Normal development to mature first-generation schizonts of the very small minority of parasites that escaped the IFN--y-mediated effects could be due to a lack of response to the lymphokine by that particular host cell.
In vivo, the antieimeria effects of IFN--y are likely to be exerted in a variety of ways, not the least of which will be mediated via the cells of the immune system. In addition to these immune-mediated effects, the results described here indicate that the lymphokine is capable of exerting a more direct antiparasite effect, manifest by (i) rendering the host cell less susceptible to invasion and (ii) inducing intracellular changes that adversely affect the transformation of the sporozoites (and possibly other invasive stages) and bring about their destruction. That these effects were demonstrable in vitro, not only with highly IFN-sensitive L-929 fibroblastlike cells (which are not hosts to eimeria in vivo) but also with RATEC epithelial cells, suggests that such mechanisms could operate in vivo in infected animals.
